first large study of glp 1 receptor agonists during pregnancy GLP-1 Agonists, Fertility Restoration, and Reproductive Safety in Women Reproductive Age: A Narrative Review Use of GLP1 receptor agonists
Description
doi: 10.1093/ajhp/62.2.173
Antidiabetogenic effect of glucagon-like peptide-1 (736)amide in normal subjects and patients with diabetes mellitus
Abstract Background Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are widely used for the management of type 2 diabetes and obesity, yet their long-term cardiovascular effects in high-risk populations continue to be actively evaluated
has received travel support from Novartis and Sanofi and research funding from Novartis
New interpretation of oral glucose tolerance
Although Ozempic isnt approved for weight management in Canada, its widely prescribed off-label for that purpose
